1. Fu, Ling-Ling, Yan, Ming, Ma, Min-Xian, Feng, Hong-Chao, Smeets, Ralf. 2022. DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma. In Frontiers in immunology, 13, 939344. doi:10.3389/fimmu.2022.939344. https://pubmed.ncbi.nlm.nih.gov/35844572/
2. Cardin, Guillaume B, Bernard, Monique, Rodier, Francis, Christopoulos, Apostolos. 2021. DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma. In Scientific reports, 11, 12753. doi:10.1038/s41598-021-92090-6. https://pubmed.ncbi.nlm.nih.gov/34140574/
3. Feng, Qi, Yu, Chao, Guo, Lingling, Han, Mei, Nie, Lei. 2024. DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells. In Arteriosclerosis, thrombosis, and vascular biology, 45, 198-217. doi:10.1161/ATVBAHA.123.320443. https://pubmed.ncbi.nlm.nih.gov/39665138/
4. Shen, Zhigang, Li, Mei, Zhu, He, Song, Tao. 2024. TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. In Functional & integrative genomics, 24, 221. doi:10.1007/s10142-024-01496-8. https://pubmed.ncbi.nlm.nih.gov/39586885/
5. Yang, Chenchen, Stueve, Theresa Ryan, Yan, Chunli, Marconett, Crystal N, Offringa, Ite A. 2018. Positional integration of lung adenocarcinoma susceptibility loci with primary human alveolar epithelial cell epigenomes. In Epigenomics, 10, 1167-1187. doi:10.2217/epi-2018-0003. https://pubmed.ncbi.nlm.nih.gov/30212242/
6. Xu, Dafeng, Wang, Yu, Liu, Xiangmei, Chen, Liang, Zheng, Jinfang. 2020. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma. In Pharmacological research, 164, 105370. doi:10.1016/j.phrs.2020.105370. https://pubmed.ncbi.nlm.nih.gov/33316381/
智鼠故事 
